CARGO II Results on XDx's AlloMap Provide Validation for European Heart ... GenomeWeb By Turna Ray XDx presented data last week that provided further confirmation that its AlloMap molecular diagnostic test can accurately assess which patients are at low risk for heart transplant rejection and therefore can avoid invasive biopsy ... |
